INFILTRATING LOBULAR CARCINOMA OF THE BREAST
Versandkostenfrei!
Versandfertig in 6-10 Tagen
45,99 €
inkl. MwSt.
PAYBACK Punkte
23 °P sammeln!
Infiltrating lobular carcinoma (ILC) of the breast is a rare histological entity, accounting for between 5% and 15% of all breast cancers.It is classified as the second most frequent histological type, after non-specific infiltrating cancer (NIC). The aims of our work were to describe the anatomo-clinical particularities and therapeutic modalities, to specify the role of breast imaging in the positive diagnosis and to identify the main prognostic factors.We carried out a retrospective descriptive study of 30 observations of CLI of the breast collected in the Obstetrics and Gynaecology Departme...
Infiltrating lobular carcinoma (ILC) of the breast is a rare histological entity, accounting for between 5% and 15% of all breast cancers.It is classified as the second most frequent histological type, after non-specific infiltrating cancer (NIC). The aims of our work were to describe the anatomo-clinical particularities and therapeutic modalities, to specify the role of breast imaging in the positive diagnosis and to identify the main prognostic factors.We carried out a retrospective descriptive study of 30 observations of CLI of the breast collected in the Obstetrics and Gynaecology Department of the Monastir Maternity and Neonatology Centre over a 10-year period. The incidence of CLI in our study was 4%. The mean age at onset of CLI was 53.43 years. A breast nodule was the most frequent revealing sign, characterized by multifocal and bilateral lesions, hence the importance of MRI. CLI appears to have a good prognosis, as it is often of low histopronostic grade, and its mode ofevolution is often insidious, with positive hormone receptors in the majority of cases.
Andere Kunden interessierten sich für
